Aurobindo Pharma Ltd.
- ECONOMY
Aurobindo Pharma’s Andhra Pradesh Unit Gets Three U.S. FDA Observations
Aurobindo Pharma on Tuesday said that the U.S. health regulator has issued Form 483 with three observations after inspecting its…
Read More » - ECONOMY
Pharma Q1 Preview – Price Erosions In The U.S., Other Markets To Drive Muted Growth In Sales: KRChoksey
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Pharma, Healthcare Q1 Preview – Expect Tepid Performance With High Base, Elevated Costs: ICICI Securities
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Pharma Q1 Earnings Preview – Recovery In U.S. But High Domestic Base To Weigh: ICICI Direct
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Q1 FY23 Earnings Preview – Management Commentaries On Demand Critical: Axis Securities
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Q1 FY23 Earnings Preview – A Glass Half-Full: Motilal Oswal
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Pharma Q1 Earnings Preview – Cost Pressure Remains: Centrum Broking
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Q3 Earnings Review – Festive Season Brings Limited Cheer; Cost Inflation Impairs Gross Margins: Motilal Oswal
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Q3 FY22 Earnings Review – Growth Momentum Continues Unabated: ICICI Direct
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More »
